|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Operating expenses: | ||||
| Research and development | ||||
| General and administrative | ||||
| Total operating expenses | ||||
| Loss from operations | ||||
| Other income: | ||||
| Gain from equity method investment | ||||
| Other income, net | ||||
| Loss before provision (benefit) for income taxes | ||||
| Provision (benefit) for income taxes | ||||
| Net loss | ||||
| Net loss per share — basic (in dollars per share) | ||||
| Net loss per share — diluted (in dollars per share) | ||||
| Weighted average common shares outstanding—diluted (in shares) |
Loading...
